Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shom Goel

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Cold Spring Harbor Perspectives in Medicine|January 8, 2023
Emerging Therapies for Breast CancerShom Goel, Sarat Chandarlapaty
Immunology and Cell Biology|December 6, 2020
Transforming growth factor β in breast cancer: another new trick for the old dogKun-Hui Lu, Shom Goel
Oncotarget|July 9, 2016
CDK4/6 inhibition: the late harvest cycle beginsShom Goel, Jean J Zhao
Breast Cancer Research : BCR|March 6, 2022
Cellular mechanisms underlying response and resistance to CDK4/6 inhibitors in the treatment of hormone receptor-positive breast cancerApril C Watt, Shom Goel
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2010
Troponin I as a predictor for trastuzumab-related cardiotoxicity: current data do not provide mechanistic insights or allow for incorporation into clinical practiceShom Goel, Jane M Beith
The Lancet. Oncology|October 3, 2019
CDK4/6 inhibitors in breast cancer: a role in triple-negative disease?Shom Goel, Sara M Tolaney
Oncology (Williston Park, N.Y.)|November 18, 2015
POINT: HER2-Targeted Combinations in Advanced HER2-Positive Breast CancerShom Goel, Eric P Winer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2015
Deciphering the role of phosphatidylinositol 3-kinase mutations in human epidermal growth factor receptor 2-positive breast cancerShom Goel, Ian E Krop
Current Breast Cancer Reports|May 9, 2017
CDK4/6 Inhibition in Breast Cancer: Mechanisms of Response and Treatment FailureAna C Garrido-Castro, Shom Goel
Translational Cancer Research|February 4, 2022
Trastuzumab-related cardiotoxicity: what do we know in 2020?Jia Liu, Shom Goel, Jane McNeil Beith
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Cold Spring Harbor Perspectives in Medicine|January 8, 2023
Emerging Therapies for Breast CancerShom Goel, Sarat Chandarlapaty
Immunology and Cell Biology|December 6, 2020
Transforming growth factor β in breast cancer: another new trick for the old dogKun-Hui Lu, Shom Goel
Oncotarget|July 9, 2016
CDK4/6 inhibition: the late harvest cycle beginsShom Goel, Jean J Zhao
Breast Cancer Research : BCR|March 6, 2022
Cellular mechanisms underlying response and resistance to CDK4/6 inhibitors in the treatment of hormone receptor-positive breast cancerApril C Watt, Shom Goel
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2010
Troponin I as a predictor for trastuzumab-related cardiotoxicity: current data do not provide mechanistic insights or allow for incorporation into clinical practiceShom Goel, Jane M Beith
The Lancet. Oncology|October 3, 2019
CDK4/6 inhibitors in breast cancer: a role in triple-negative disease?Shom Goel, Sara M Tolaney
Oncology (Williston Park, N.Y.)|November 18, 2015
POINT: HER2-Targeted Combinations in Advanced HER2-Positive Breast CancerShom Goel, Eric P Winer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2015
Deciphering the role of phosphatidylinositol 3-kinase mutations in human epidermal growth factor receptor 2-positive breast cancerShom Goel, Ian E Krop
Current Breast Cancer Reports|May 9, 2017
CDK4/6 Inhibition in Breast Cancer: Mechanisms of Response and Treatment FailureAna C Garrido-Castro, Shom Goel
Translational Cancer Research|February 4, 2022
Trastuzumab-related cardiotoxicity: what do we know in 2020?Jia Liu, Shom Goel, Jane McNeil Beith
Pageof 7